These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36343537)

  • 1. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
    Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
    J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway.
    Grover P; Bhardwaj M; Mehta L
    J Pharm Biomed Anal; 2021 Nov; 206():114351. PubMed ID: 34509659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
    Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
    J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
    Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
    J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
    Mahesh M; Bali A; Gupta T
    Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
    Matta A; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
    Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
    J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
    Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
    Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
    Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
    Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
    P J; Ch V; A L; V G M N; Ch N; N S
    J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
    Kalariya PD; Talluri MV; Patel PN; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, characterization, and in silico ADMET prediction of nirmatrelvir and its degradation products using HPLC-PDA and LC-QTOF-MS/MS.
    Kumar MA; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Oct; 38(20):e9896. PubMed ID: 39185574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.